Keywords: almirall, nine-month, profit, jumps, leading, spanish, drugmaker
Almirall's nine-month profit jumps 5.3%
Article | 24 November 2008
Leading Spanish drugmaker Almirall's net income in the first nine months of 2008 reached 132.6 million euros ($169.8 million), an increase of 5.3% year-on-year, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
